EDEM2 stably disulfide-bonded to TXNDC11 catalyzes the first mannose trimming step in mammalian glycoprotein ERAD.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32065582.
- Also identified by DOI 10.7554/eLife.53455 and PMC identifier 7039678.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Sequential mannose trimming of N-glycan (Man<sub>9</sub>GlcNAc<sub>2</sub> -> Man<sub>8</sub>GlcNAc<sub>2</sub> -> Man<sub>7</sub>GlcNAc<sub>2</sub>) facilitates endoplasmic reticulum-associated degradation of misfolded glycoproteins (gpERAD). Our gene knockout experiments in human HCT116 cells have revealed that EDEM2 is required for the first step. However, it was previously shown that purified EDEM2 exhibited no α1,2-mannosidase activity toward Man<sub>9</sub>GlcNAc<sub>2</sub> in vitro. Here, we found that EDEM2 was stably disulfide-bonded to TXNDC11, an endoplasmic reticulum protein containing five thioredoxin (Trx)-like domains. C558 present outside of the mannosidase homology domain of EDEM2 was linked to C692 in Trx5, which solely contains the CXXC motif in TXNDC11. This covalent bonding was essential for mannose trimming and subsequent gpERAD in HCT116 cells. Furthermore, EDEM2-TXNDC11 complex purified from transfected HCT116 cells converted Man<sub>9</sub>GlcNAc<sub>2</sub> to Man<sub>8</sub>GlcNAc<sub>2</sub>(isomerB) in vitro. Our results establish the role of EDEM2 as an initiator of gpERAD, and represent the first clear demonstration of in vitro mannosidase activity of EDEM family proteins.
Medical subject headings
- Carrier Proteins
- Endoplasmic Reticulum-Associated Degradation
- Glycoproteins
- Mannose
- alpha-Mannosidase